8 Patent Results (5 families)
Make Note

Protein-protein Interactions In Human Immunodeficiency Virus

  • Published: Jan 14, 2009
  • Filed: Nov 26, 2002
  • Earliest Priority: Nov 26 2001
  • Family: 17
  • Cited Works: 80
  • Cited by: 0
  • Cites: 17
  • Sequences: 132
  • Additional Info: Cited Works Published Sequence
  • Applicant: Cellvir
Patent Application
EP 2014674 A1
143-733-044-697-238

Human Immunodeficiency Virus Integrase-ledgf P75 Isoform Protein-protein Interactions

  • Published: Jul 27, 2010
  • Filed: May 26, 2004
  • Earliest Priority: Nov 26 2001
  • Family: 17
  • Cited Works: 52
  • Cited by: 0
  • Cites: 4
  • Sequences: 162
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Hivih, Laboratoire Biodim, Centre National De La Recherche Scientifique (20 Percent Interest), Inserm-transfert S.a. (20 Percent Interest), Paris Descartes University (10 Percent Interest), Cellvir, Hybrigenics
  • Applicant: Cellvir
Granted Patent
US 7763254 B2
086-659-544-444-642

Methods For Increasing Immune Responses Using Agents That Directly Bind To And Activate Ire-1

  • Published: May 1, 2018
  • Filed: Feb 7, 2012
  • Earliest Priority: Feb 07 2011
  • Family: 4
  • Cited Works: 807
  • Cited by: 1
  • Cites: 142
  • Additional Info: Cited Works Full text Published
  • Owner: Cornell University, President And Fellows Of Harvard College
  • Applicant: Glimcher Laurie H, Bettigole Sarah, Martinon Fabio, Univ Cornell
Granted Patent
US 9956236 B2
080-337-269-491-750

Anti-malignant Tumor Agent Composition

  • Published: Nov 19, 2015
  • Filed: Jun 7, 2014
  • Earliest Priority: May 15 2014
  • Family: 10
  • Cited Works: 75
  • Cited by: 1
  • Cites: 2
  • Additional Info: Cited Works Full text Published
  • Applicant: Pharma Co Ltd J
Patent Application
WO 2015/173970 A1
093-558-723-729-257

Methods And Pharmaceutical Compositions For The Treatment Of Diseases Associated With Reduced Cftr Function

  • Published: Oct 25, 2018
  • Filed: Apr 20, 2018
  • Earliest Priority: Apr 21 2017
  • Family: 1
  • Cited Works: 126
  • Cited by: 0
  • Cites: 10
  • Additional Info: Cited Works Full text Published
  • Applicant: Inst Nat Sante Rech Med, Univ De Bretagne Occidentale, Etablissement Francais Du Sang Efs, Centre Hospitalier Regional Et Univ De Brest
Patent Application
WO 2018/193075 A1
178-032-894-525-625

Compounds For Inducing Anti-tumor Immunity And Methods Thereof

Granted Patent
US 9957506 B2
139-233-813-707-395

Compounds For Inducing Anti-tumor Immunity And Methods Thereof

Granted Patent
US 10421965 B2
125-212-375-043-988

Compounds For Inducing Anti-tumor Immunity And Methods Thereof

  • Published: Oct 22, 2019
  • Filed: Mar 14, 2018
  • Earliest Priority: Sep 25 2013
  • Family: 13
  • Cited Works: 795
  • Cited by: 0
  • Cites: 144
  • Sequences: 42
  • Additional Info: Cited Works Full text Sequence
  • Owner: Cornell University
  • Applicant: Univ Cornell
Granted Patent
US 10450566 B2
100-982-176-120-227
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback